B. S. Biotech Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 0.11 M
- Company Age 17 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 2.50 M
- Revenue Growth -24.06%
- Profit Growth -9.42%
- Ebitda -49.09%
- Net Worth 29.31%
- Total Assets 5.86%
About B. S. Biotech
B. S. Biotech Private Limited (BSBPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 11 September 2007 and has a history of 17 years and five months. Its registered office is in North 24 Parganas, West Bengal, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.11 M.
The company has closed loans amounting to ₹2.50 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Probir Das, Jayasri Das, Sagnik Das, and One other member serve as directors at the Company.
Company Details
- Location
North 24 Parganas, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85190WB2007PTC118476
- Company No.
118476
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Sep 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at B. S. Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Probir Das  | Managing Director | 11-Sep-2007 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jayasri Das | Director | 01-Nov-2011 | Current |
| Sagnik Das | Director | 24-Mar-2021 | Current |
| Soumi Das | Director | 30-May-2024 | Current |
Financial Performance of B. S. Biotech.
B. S. Biotech Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 24.06% decrease. The company also saw a slight decrease in profitability, with a 9.42% decrease in profit. The company's net worth Soared by an impressive increase of 29.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of B. S. Biotech?
Unlock access to B. S. Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Inno Hexa Vet Private LimitedProbir Das is a mutual person
- Osaro Exim Private Limited
Probir Das, Jayasri Das and 2 more are mutual person
Charges (Loans)
₹0
₹2.50 M
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 0.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Sep 2018 | Axis Bank Limited | ₹2.50 M | Satisfied |
How Many Employees Work at B. S. Biotech?
Unlock and access historical data on people associated with B. S. Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of B. S. Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped B. S. Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
